Form 4: Procter & Gamble Executive Acquires Stock Options

Moses Victor Javier Aguilar, a Chief Research, Development & Innovation Officer at Procter & Gamble, reports the acquisition of stock options.

Summary

• On September 13, 2024, Moses Victor Javier Aguilar, a Chief Research, Development & Innovation Officer at Procter & Gamble, reported a transaction.
• Aguilar acquired 5,932 stock options with an exercise price of $174.08, exercisable from September 13, 2027, to September 13, 2034.
• Following the transaction, Aguilar directly owns 21,018.7898 shares of common stock.
• Aguilar also indirectly owns 6,117.2612 shares through a retirement plan trustee and 428.6033 shares through the International Stock Ownership Plan (Mexico) Trustee.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of an insider transaction. It doesn't inherently indicate positive or negative sentiment, but rather provides information about an executive's holdings.

Positives

• The acquisition of stock options by a high-ranking executive could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their holdings in the company's stock.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• The terms of these options, such as the exercise price and vesting schedule, are generally benchmarked against industry standards and peer companies.
• Companies like Unilever, Nestle, and Johnson & Johnson also utilize stock options as part of their executive compensation plans.

Stakeholder Impact

• Shareholders may be interested in this information as it provides insight into the actions of company executives.
• The transaction itself is unlikely to have a significant impact on other stakeholders.

Key Dates